Although cytotoxic CD8 T cells have been considered to be the main protagonists in the production of anti-tumor therapeutic effects resulting from vaccines, increasingly, several aspects of CD4 T-cell biology suggest that this T-cell population can effectively be used for cancer immunotherapy. The gene discussed is CD8A; the disease is cancer.